Abstract
Cetuximab is a human-murine chimeric monoclonal antibody to the epidermal growth factor receptor, active for advanced colorectal cancer treatment in combination with chemotherapy. Cetuximab mainly acts by inhibiting epidermal growth factor receptor-mediated pathways in cancer cells; however, in the human host, its IgG1 backbone may offer additional antitumor activity that includes FcγRs-mediated antibody-dependent cell cytotoxicity, phagocytosis, cross priming, and tumor-specific T-cell-mediated immune response. These mechanisms are still under active investigation. At this purpose, we have performed an immunologic investigation in advanced colon cancer patients enrolled in an ongoing phase II trial aimed to test the toxicity and the biological and antitumor activity of a novel biochemotherapy regimen combining polychemotherapy with gemcitabine, irinotecan, levofolinic acid, and fluorouracil with cetuximab and with subcutaneous low-dose metronomic aldesleukin (GILFICet regimen). The peripheral blood mononuclear cells of the first 20 patients enrolled in the GILFICet trial were collected at baseline and after 6 treatment cycles and examined for immune-phenotype change by flow cytometry. Colon cancer-specific T-cell lines were al...Continue Reading
Citations
Nov 19, 2013·PloS One·Anita K GandhiRajesh Chopra
Jun 19, 2014·PloS One·Annika ÅlgarsOlli Carpén
Dec 18, 2012·Immunotherapy·José Medina-Echeverz, Pedro Berraondo
Apr 14, 2015·Seminars in Cancer Biology·W G JiangD Santini
May 23, 2013·Expert Opinion on Biological Therapy·Marco RossiPierosandro Tagliaferri
May 4, 2016·Oncoimmunology·Pierpaolo CorrealeMaria Grazia Cusi
Jun 11, 2015·Cancer Biology & Therapy·Domenico CilibertoPierosandro Tagliaferri
Jun 3, 2015·Cancer Immunology, Immunotherapy : CII·Maria Grazia CusiPierpaolo Correale
Jun 14, 2013·Cancer Biology & Therapy·Cirino BottaPierpaolo Correale
Dec 30, 2014·Frontiers in Oncology·Cirino BottaPierfrancesco Tassone
Oct 19, 2016·Cell Death Discovery·E C MartinoP Correale
Oct 30, 2016·Cancer Biology & Therapy·Valerio NardonePierpaolo Correale
Dec 17, 2016·Blood Cancer Journal·C BottaP Tassone
Dec 21, 2016·Immunotherapy·Pierpaolo CorrealePierosandro Tagliaferri
Nov 22, 2017·Leukemia·C BottaP Tassone
Jun 20, 2014·Molecular Pharmacology·Ronald P Taylor, Margaret A Lindorfer
May 8, 2018·Oncotarget·Marco RossiPierfrancesco Tassone
May 15, 2018·Oncotarget·Pierpaolo CorrealePierosandro Tagliaferri
Oct 17, 2019·Frontiers in Oncology·Jesús García-FoncillasSebastian Stintzing
Jun 25, 2016·World Journal of Gastroenterology : WJG·Xiang LiWei-Dong Han
Nov 30, 2019·Frontiers in Oncology·Michele CaragliaPierosandro Tagliaferri
Mar 28, 2020·Molecular Carcinogenesis·Hang RuanJian Yu
Apr 3, 2015·Cancer Research·Hyun-Bae JieRobert L Ferris
Nov 10, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A G Duffy, T F Greten
Jul 3, 2021·Cancers·Cirino BottaMassimo Gentile
Jul 3, 2021·International Journal of Molecular Sciences·Cirino BottaPierpaolo Correale